Stem cells are renowned for their capacity to differentiate into various types of cells. This is why they have such an impressive capacity for regenerating tissue like skin, muscles, bones, tendons, and ligaments.
A long-anticipated Phase 3 clinical trial into the effectiveness of hematopoietic stem cell transplantation for treating multiple sclerosis has just been announced. The trial will be conducted by the U.S. National Institutes of Health and will recruit patients from both the United States and United Kingdom.
It is estimated that more than 15 million babies are born prematurely each year. A large percentage of these babies will develop chronic lung disease, a dangerous condition which makes it much harder to breathe.
Blood disorders are diseases that affect one of the components of blood — red blood cells (which carry oxygen), white blood cells (which fight infections), or platelets (which help the blood clot). Some blood disorders can also affect the liquid portion of blood, called plasma.
A recent study published in Annals of Hematology has reported that allogenic cord blood stem cell transplants are effective at treating relapsed/refractory diffuse large B-cell lymphoma (DLBCL). This important discovery confirms to doctors that allogenic transplants are a viable treatment option for patients with B-cell lymphoma.
A new research paper published in the journal Stem Cells describes how a team of scientists has developed a potential new treatment for brittle bones using stem cells. The study, called “Engraftment of skeletal progenitor cells by bone directed transplantation improves osteogenesis imperfecta murine bone phenotype” could lead to a cure for osteogenesis imperfecta and several other degenerative bone diseases.
Scientists have made some incredible breakthroughs in the field of stem cell research in the past few decades. These breakthroughs have resulted in stem cells being used to treat more than 80 different diseases, including many forms of cancer, immune system disorders, metabolic disorders, and blood disorders.
Chemotherapy and radiation therapy have been the most commonly used forms of cancer treatment for many decades. Although both treatment are effective at killing cancer cells, they are both toxic to healthy cells in the body, which causes several serious side effects.
Japanese researchers have been at the forefront of stem cell research for many years. They have been the source of several exciting breakthroughs including the development of induced pluripotent stem cells (iPSCs).
A team of researchers in the United States has developed a new biosensor system that makes it easier to monitor how stem cells change into mature cells. This breakthrough will help scientists understand the progression of diseases like Parkinson’s disease, making it easier to develop effective treatments.